AAAAAA

   
Results: 1-9 |
Results: 9
Peripheral blood CD4(+) T cells in systemic lupus erythematosus
Authors: Horwitz, DA
Citation: Da. Horwitz, Peripheral blood CD4(+) T cells in systemic lupus erythematosus, LUPUS, 10(5), 2001, pp. 319-320
Transforming growth factor beta enhances the expression of CD154 (CD40L) and production of tumor necrosis factor alpha by human T lymphocytes
Authors: Gray, JD Liu, TF Huynh, N Horwitz, DA
Citation: Jd. Gray et al., Transforming growth factor beta enhances the expression of CD154 (CD40L) and production of tumor necrosis factor alpha by human T lymphocytes, IMMUNOL LET, 78(2), 2001, pp. 83-88
A role for TGF-beta in the generation and expansion of CD4(+)CD25(+) regulatory T cells from human peripheral blood
Authors: Yamagiwa, S Gray, JD Hashimoto, S Horwitz, DA
Citation: S. Yamagiwa et al., A role for TGF-beta in the generation and expansion of CD4(+)CD25(+) regulatory T cells from human peripheral blood, J IMMUNOL, 166(12), 2001, pp. 7282-7289
Role of NK cells and TGF-beta in the regulation of T-cell-dependent antibody production in health and autoimmune disease
Authors: Horwitz, DA Gray, JD Ohtsuka, K
Citation: Da. Horwitz et al., Role of NK cells and TGF-beta in the regulation of T-cell-dependent antibody production in health and autoimmune disease, MICROBES IN, 1(15), 1999, pp. 1305-1311
Impaired cytotoxic T lymphocyte activity in systemic lupus erythematosus following in vitro polyclonal T cell stimulation: a contributory role for non-T cells
Authors: Stohl, W Hamilton, AS Deapen, DM Mack, TM Horwitz, DA
Citation: W. Stohl et al., Impaired cytotoxic T lymphocyte activity in systemic lupus erythematosus following in vitro polyclonal T cell stimulation: a contributory role for non-T cells, LUPUS, 8(4), 1999, pp. 293-299
The relationship between defects in lymphocyte production of transforming growth factor-beta(1) in systemic lupus erythematosus and disease activity or severity
Authors: Ohtsuka, K Gray, JD Stimmler, MM Horwitz, DA
Citation: K. Ohtsuka et al., The relationship between defects in lymphocyte production of transforming growth factor-beta(1) in systemic lupus erythematosus and disease activity or severity, LUPUS, 8(2), 1999, pp. 90-94
Cytokine-mediated down-regulation of B cell activity in SLE: effects of interleukin-2 and transforming growth factor-beta
Authors: Ohtsuka, K Gray, JD Quismorio, FP Lee, W Horwitz, DA
Citation: K. Ohtsuka et al., Cytokine-mediated down-regulation of B cell activity in SLE: effects of interleukin-2 and transforming growth factor-beta, LUPUS, 8(2), 1999, pp. 95-102
Etanercept therapy in rheumatoid arthritis - A randomized, controlled trial
Authors: Moreland, LW Schiff, MH Baumgartner, SW Tindall, EA Fleischmann, RM Bulpitt, KJ Weaver, AL Keystone, EC Furst, DE Mease, PJ Ruderman, EM Horwitz, DA Arkfeld, DG Garrison, L Burge, DJ Blosch, CM Lange, MLM McDonnell, ND Weinblatt, ME
Citation: Lw. Moreland et al., Etanercept therapy in rheumatoid arthritis - A randomized, controlled trial, ANN INT MED, 130(6), 1999, pp. 478
Natural killer cells and CD8(+) T cells in the downregulation of antibody production in healthy subjects and SLE - A role for transforming growth factor-beta and interleukin-2
Authors: Horwitz, DA Gray, JD Ohtsuka, K Toro, B Stimmler, MM Hsu, L
Citation: Da. Horwitz et al., Natural killer cells and CD8(+) T cells in the downregulation of antibody production in healthy subjects and SLE - A role for transforming growth factor-beta and interleukin-2, CONT IMMUN, 7, 1999, pp. 312-320
Risultati: 1-9 |